Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04662801 · ClinicalTrials.gov registry record · Phase 2
Weight Regain Treatment Post-Bariatric Surgery
A Phase 2 study of Obesity & Overweight, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT04662801 is a Phase 2 study of Obesity & Overweight that has completed, run by Yale University. The registered enrollment target is 26 participants, below the 127-participant average among 15 other Obesity & Overweight trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04662801, a Phase 2 study of Obesity & Overweight, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine behavioral and pharmacologic (Naltrexone+Bupropion) treatments for weight regain after bariatric surgery.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Weight Loss (BWL)
- BEHAVIORAL Early Responder: BWL continued
- COMBINATION_PRODUCT Early Non-responder: BWL continued with medication added
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2022-09-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04662801
The ClinicalTrials.gov registry entry for NCT04662801 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 127-participant average among 15 other Obesity & Overweight trials with a reported enrollment target (80% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity & Overweight appearing as the primary indexed condition, and to 3 interventions - of which Behavioral Weight Loss (BWL) is the first listed.
NCT04662801 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04662801 about?
NCT04662801 is a clinical study titled "Weight Regain Treatment Post-Bariatric Surgery". This study will examine behavioral and pharmacologic (Naltrexone+Bupropion) treatments for weight regain after bariatric surgery.
What is the current status of trial NCT04662801?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2021-08-05. Estimated completion is 2022-09-13.
What conditions does trial NCT04662801 study?
This clinical trial studies the following conditions: Obesity & Overweight.
What interventions are being tested in trial NCT04662801?
The interventions under investigation include: Behavioral Weight Loss (BWL) (BEHAVIORAL), Early Responder: BWL continued (BEHAVIORAL), Early Non-responder: BWL continued with medication added (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04662801?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04662801 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity & Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
RECRUITING · NA
-
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
RECRUITING · NA
-
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
RECRUITING · NA
-
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.